Stay updated on Navarixin and Pembrolizumab Combination Clinical Trial

Sign up to get notified when there's something new on the Navarixin and Pembrolizumab Combination Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Navarixin and Pembrolizumab Combination Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.6%
    Check dated 2025-06-19T19:57:09.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:20:48.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T06:05:20.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page has added a new publication regarding a phase 2 randomized trial of the CXCR2 antagonist navarixin in combination with pembrolizumab, while the previous version has been deleted due to an erratum.
    Difference
    0.2%
    Check dated 2025-05-22T03:36:15.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T14:17:31.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study information regarding the efficacy and safety of navarixin in combination with pembrolizumab for specific solid tumors, and the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    31%
    Check dated 2025-04-16T10:06:01.000Z thumbnail image

Stay in the know with updates to Navarixin and Pembrolizumab Combination Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Navarixin and Pembrolizumab Combination Clinical Trial page.